TrialCancer chemotherapy and pharmacology2019

A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias.

Tara L Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.